Skip to main content
Top

Drugs

Issue 2/2022

Content (9 Articles)

New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice

Marc Evans, Angharad R. Morgan, Martin B. Whyte, Wasim Hanif, Stephen C. Bain, Philip A. Kalra, Sarah Davies, Umesh Dashora, Zaheer Yousef, Dipesh C. Patel, W. David Strain

Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy

Jorge Rojas-Rivera, Fernando C. Fervenza, Alberto Ortiz

Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets

  • Open Access
  • Review Article

Deanna H. Dang, Kamran M. Riaz, Dimitrios Karamichos

Gastrointestinal Dysfunction in Parkinson’s Disease

Delaram Safarpour, Kaveh Sharzehi, Ronald F. Pfeiffer

Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis

Simona Lattanzi, Eugen Trinka, Gaetano Zaccara, Pasquale Striano, Emilio Russo, Cinzia Del Giovane, Mauro Silvestrini, Francesco Brigo

Asciminib: First Approval

Emma D. Deeks

Somatrogon: First Approval

  • AdisInsight Report

Yvette N. Lamb

Envafolimab: First Approval

Anthony Markham

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images